How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Split Septum Needleless Connector Market
- By Material Type: Polycarbonate (PC), Polypropylene (PP), Stainless Steel, Silicone
- By Connector Design: Split Septum, Rotating Valve, Mechanical Valve, Negative Pressure Valve
- By Application: Intravenous (IV) Therapy, Blood Sampling, Drug Delivery, Parenteral Nutrition
- By End-User: Hospitals, Ambulatory Care Centers, Home Healthcare, Clinics
- By Sterilization Method: Ethylene Oxide (EO) Sterilization, Gamma Radiation Sterilization, Steam Sterilization (Autoclave)
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Polycarbonate (PC) leads By Material Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 17 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 296 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.175 →
- 12 Company Profiles 17 players: SWOT & benchmarking p.183 →
Full report · locked preview
Everything inside the Split Septum Needleless Connector Market report
A complete, evidence-based study - 12 chapters and 124 sections covering market size, segmentation across 5 axes, regional analysis and 17 company profiles, forecast to 2033.
Segmentation covered
Material Type 4
Connector Design 4
Application 4
End-User 4
Sterilization Method 3
Companies profiled
Becton Dickinson and Company (BD)
Smiths Medical
B. Braun Melsungen AG
Terumo Corporation
Nipro Corporation
ICU Medical Inc.
Fresenius Kabi
Moog Inc.
Medline Industries Inc.
Cardinal Health Inc.
C.R. Bard
Inc. (now part of BD)
+5 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
17 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Becton Dickinson and Company (BD)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Smiths Medical
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →B. Braun Melsungen AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Terumo Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Nipro Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →ICU Medical Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Fresenius Kabi
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →Moog Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Medline Industries Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Cardinal Health Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →C.R. Bard
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Inc. (now part of BD)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Nexcare Medical Products
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.227 →Vygon SA
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →SteriLumen
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Retractable Technologies
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.250 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$4,479M by 2033 · 6.4% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Polycarbonate (PC)39.5
- Polypropylene (PP)24.6
- Stainless Steel23.8
- Silicone12.0
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$897.7M → $1,420M · 5.9%
Europe$625.6M → $994.3M · 6.0%
Asia Pacific$571.2M → $899.7M · 5.8%
Latin America$353.6M → $517.1M · 4.9%
Middle East and Africa$272.0M → $456.7M · 6.7%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →6.372026
6.402027
6.412028
6.422029
6.432030
6.442031
6.462032
6.462033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Becton Dickinson and Company (BD)23.3
- Smiths Medical22.5
- B. Braun Melsungen AG6.1
- Terumo Corporation5.7
- Nipro Corporation8.3
- ICU Medical Inc.6.1
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Material Type30.3%
Connector Design20.0%
Application14.7%
End-User24.5%
Sterilization Method10.4%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America33.1
- Europe23.2
- Asia Pacific21.0
- Latin America12.1
- Middle East and Africa10.7
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Becton Dickinson and Company (BD) | 93 | 84 | 91 | 95 | 88 | 76 | 88 |
| Smiths Medical | 93 | 89 | 73 | 71 | 92 | 68 | 81 |
| B. Braun Melsungen AG | 83 | 87 | 79 | 82 | 70 | 87 | 81 |
| Terumo Corporation | 60 | 82 | 65 | 62 | 59 | 70 | 66 |
| Nipro Corporation | 64 | 55 | 73 | 69 | 68 | 54 | 64 |
| ICU Medical Inc. | 61 | 59 | 47 | 56 | 63 | 55 | 57 |
| Fresenius Kabi | 58 | 50 | 46 | 42 | 44 | 61 | 50 |
| Moog Inc. | 55 | 55 | 49 | 42 | 48 | 46 | 49 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Becton Dickinson and Company (BD)
- Smiths Medical
- B. Braun Melsungen AG
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Becton Dickinson and Company (BD) | ◐ | ✓ | ✓ | ✓ | ✓ | ◐ |
| Smiths Medical | ◐ | ✓ | − | ◐ | ✓ | ◐ |
| B. Braun Melsungen AG | ✓ | ◐ | ✓ | ✓ | ◐ | ◐ |
| Terumo Corporation | ◐ | ✓ | ◐ | − | ◐ | ◐ |
| Nipro Corporation | − | − | ◐ | ◐ | ◐ | ◐ |
| ICU Medical Inc. | ◐ | − | ◐ | − | − | − |
| Fresenius Kabi | − | − | − | ◐ | ◐ | − |
| Moog Inc. | ◐ | ◐ | ◐ | − | ◐ | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Becton Dickinson and Company (BD)88
2Smiths Medical81
3B. Braun Melsungen AG81
4Terumo Corporation66
5Nipro Corporation64
6ICU Medical Inc.57
7Fresenius Kabi50
8Moog Inc.49
Competitive tiers
§8.4 · p.172 →Leader3
Set the pace on share, breadth and innovation.
Becton Dickinson and Company (BD)Smiths MedicalB. Braun Melsungen AG
Contender3
Focused players with pockets of strength.
Terumo CorporationNipro CorporationICU Medical Inc.
Niche2
Specialists in a single segment or region.
Fresenius KabiMoog Inc.
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Material Type in North America, then scale across Split Septum Needleless Connector Market — a $263M beachhead inside a $3.78B market.
Beachhead (SOM)$263Mobtainable near-term
Serviceable (SAM)$1.53Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale6 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion90 fit
Polycarbonate (PC)
Best fit — highest urgency & budget in Material Type.
Economic buyer75 fit
Polypropylene (PP)
Strong fit — clear ROI and a fast path to value.
End user69 fit
Stainless Steel
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Material Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Connector Design & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Application
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales45%
Partner / channel26%
Digital / self-serve23%
Marketplaces6%
Positioning & messaging
§GTM 2 · p.194 →For Material Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Split Septum Needleless Connector Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified40%
Sales qualified22%
Evaluation14%
Closed-won7%
$10.1KCAC
$45KLTV
4.4:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Split Septum Needleless Connector Market is a high-growth opportunity — $1.78B by 2033, compounding at 11.5%.
TAM · 2025$749Mtoday
TAM · 2033$1.78Bforecast
CAGR11.5%2027–2033
Cumulative$10.8Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$1.78BTotal addressable market
SAM$680MServiceable available market
SOM$111MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →11.5% CAGR
Demand compounds through 2033, outpacing GDP across Material Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Material Type moving from early to mainstream — durable secular demand.
Consolidation upside
17+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$1.78BLarge & growingTAM by 2033 at 11.5% CAGR
$680MServiceable nowreachable with today’s model
$111MBeachhead winobtainable near-term share
17+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$1.39BBear7.5% CAGR
$1.78BBase11.5% CAGR
$2.28BBull15.1% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Connector Design optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Split Septum Needleless Connector Market — a $1.97B market by 2033. Plan: grow share from 7.3% to 14.1%.
Market size · 2033$1.97Btotal addressable
Market CAGR5.0%2027–2033
Target share14.1%from 7.3% today
Revenue ambition$278Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 7.3% | 14.1% | At risk |
| Revenue | $147M | $278M | Ahead |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | Behind |
| Gross margin | 28.7% | 43.0% | Behind |
| Customer retention | 87.5% | 95.6% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Material Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Connector Design capability
A defensible second engine — invest in Connector Design to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Material Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Connector Design
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $36M capacity & capability investment
- Greenlight bolt-on M&A in Connector Design
- Authorise North America expansion plan
- Fund R&D program for Material Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAt risk
- Competitive share lossOn track
- Input-cost & supply riskAt risk
- Regulatory / policy changeOn track
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Split Septum Needleless Connector Market conversation — a $1.52B market you can size, segment and defend in minutes.
Market size · 2033$1.52Btotal opportunity
Growth6.9%CAGR to 2033
Addressable buyers1,626+accounts in scope
Typical ROI5×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Material Type
Goal Grow share in Material Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →5×return on cost, year one
< 3 mopayback period
$88K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
17+players profiled in this market
Coverage includes
Becton Dickinson and Company (BD)Smiths MedicalB. Braun Melsungen AGTerumo CorporationNipro CorporationICU Medical Inc.Fresenius KabiMoog Inc.+9 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Split Septum Needleless Connector Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Split Septum Needleless Connector Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Split Insulin Pump Market
Market size, share, segmentation and regional forecast.
$3.7B market · 2025 base year
View reportSplit Influenza Vaccine Market
Market size, share, segmentation and regional forecast.
$2.0B market · 2025 base year
View reportSplit Health Pot Market
Market size, share, segmentation and regional forecast.
$4.6B market · 2025 base year
View reportSplit Beam UV Visible Spectrophotometers Market
Market size, share, segmentation and regional forecast.
$4.7B market · 2025 base year
View reportSpleen Tyrosine Kinase (Syk) Inhibitor Therapeutics Market
Market size, share, segmentation and regional forecast.
$925M market · 2025 base year
View reportSpleen Tyrosine Kinase (Syk) Antibody Market
Market size, share, segmentation and regional forecast.
$4.7B market · 2025 base year
View reportSpirovital Therapy Unit Market
Market size, share, segmentation and regional forecast.
$5.7B market · 2025 base year
View reportSpirostan-6-one, 3,5-dihydroxy-, (3β,5α,25R) Market
Market size, share, segmentation and regional forecast.
$4.4B market · 2025 base year
View reportSpironolactone API Market
Market size, share, segmentation and regional forecast.
$1.6B market · 2025 base year
View reportSpirometry Software Market
Market size, share, segmentation and regional forecast.
$6.0B market · 2025 base year
View reportSpirometry Machine Market
Market size, share, segmentation and regional forecast.
$5.1B market · 2025 base year
View reportSpirometer Transducers Market
Market size, share, segmentation and regional forecast.
$5.7B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.